Received Apr 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Shingrix adjuvant only given; Shingrix adjuvant only given; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Shingrix adjuvant only given) and inappropriate dose of vaccine administered (Verbatim: Shingrix adjuvant only given). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK receipt date: 14-APR-2025 Pharmacy director's assistant called to report the adjuvant portion of the Shingrix vaccine was administered which led to inappropriate dose of vaccine administered and inappropriate preparation of medication. During the call the healthcare professional reported event happened in one of their offsite offices so when details were asked about the patient, lot number or vaccination date, the information was declined because it was not available at that moment.